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Abstract
Background: Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, isolated from
the traditional Chinese herb Artemisia annua, is recommended as the first-line anti-malarial drug
with low toxicity. DHA has been shown to possess promising anticancer activities and induce
cancer cell death through apoptotic pathways, although the molecular mechanisms are not well
understood.
Methods: In this study, cell counting kit (CCK-8) assay was employed to evaluate the survival of
DHA-treated ASTC-a-1 cells. The induction of apoptosis was detected by Hoechst 33258 and PI
staining as well as flow cytometry analysis. Collapse of mitochondrial transmembrane potential
('<m) was measured by dynamic detection under a laser scanning confocal microscope and flow
cytometry analysis using Rhodamine123. Caspase-3 activities measured with or without Z-VAD-
fmk (a broad spectrum caspase inhibitor) pretreatment by FRET techniques, caspase-3 activity
measurement, and western blotting analysis.
Results: Our results indicated that DHA induced apoptotic cell death in a dose- and time-
dependent manner, which was accompanied by mitochondrial morphology changes, the loss of
'<m and the activation of caspase-3.
Conclusion: These results show for the first time that DHA can inhibit proliferation and induce
apoptosis via caspase-3-dependent mitochondrial death pathway in ASTC-a-1 cells. Our work may
provide evidence for further studies of DHA as a possible anticancer drug in the clinical treatment
of lung adenocarcinoma.
Background
Lung cancer is the leading cause of cancer death in the
United States and throughout the world [1]. For therapeu-
tic purposes, lung cancer is generally divided into small-
cell lung cancer (SCLC) or non-small-cell lung cancer
(NSCLC) [2]. Approximately 80% of lung cancer cases are
classified as NSCLC, and adenocarcinoma is now the
most common form of NSCLC [3]. Despite recent
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advances in chemotherapy, lung adenocarcinoma
remains incurable. The effectiveness of chemotherapeutic
agents is often limited by the side effects and resistance of
drug treatment [4]. It is of paramount importance to dis-
cover novel agents with less severe side effects and drug-
resistance.
Dihydroartemisinin (DHA), a semi-synthetic derivative of
artemisinin, isolated from the traditional Chinese herb
Artemisia annua, is recommended as a first-line anti-
malarial drug with low toxicity [5]. In recent years, certain
artemisinin derivatives are shown to inhibit the growth of
a limited set of human cancer cell lines [6,7], such as
leukemia cells [8,9], fibrosarcoma cells [10], ovarian cells
[11], breast cancer cells and cervical cancer cells [12-14].
Moreover, Jiao Y et al also demonstrated that DHA was
the most effective and potent agent in inhibiting cell
growth of ovarian cancer cells compared with artemisinin,
artesunate, arteether, artemether and arteannuin [11].
Apoptosis, a kind of cell death, causes specific morpho-
logical changes and DNA fragmentation that are consid-
ered as the major cytopathologic hallmarks of the
apoptotic process [15]. Most commonly, two major apop-
tosis pathways have been identified: the death receptor
pathway and the mitochondrial pathway [16]. Mitochon-
drial dysfunction, in particular the induction of the inner
mitochondrial membrane potential ('<m) depolariza-
tion, has been implicated in the cascade of events
involved in the induction of apoptosis during mitochon-
drial pathway [17]. Apoptosis signal transduction and
execution require the action of the caspases cascade and
human caspase-1 to -10 have been described that activa-
tion of caspases cascade is involved in chemicals- and
agents-induced apoptosis [18]. Caspase-3 has been shown
to be a key component involved in the underlying mech-
anisms of apoptosis [19] and the activation of caspase-3 is
considered to be the final step in many apoptosis path-
ways [20].
Although it has been found that DHA can induce apopto-
sis in various tumor cells, its molecular mechanisms
remain unclear [21]. It has been reported that DHA-
induced apoptosis might be implicated in the activation
of caspases in HL-60 cells [22], but little attention had
been paid to the molecular mechanism of DHA-induced
tumor cells apoptosis in living cells.
Fluorescence resonance energy transfer (FRET) technique
has been widely used to study protein-protein interaction
and pattern of endogenous caspase-3 activation in living
cells [23-27]. Miura et al constructed a SCAT3 plasmid, a
GFPs-based FRET probe, to monitor dynamics of caspase-
3 activation in single living cell [24]. The SCAT3 consists
of a donor (enhanced cyan fluorescent protein, ECFP), an
acceptor (Venus, a mutant of yellow fluorescent protein)
and a linking sequence containing DEVD, the caspase-3
cleavage substrate [28]. The activation of caspase-3 leads
to the cleavage of the linker, and significantly reduces the
efficiency of FRET of SCAT3 [24].
In our study, we treated human lung adenocarcinoma
(ASTC-a-1) cells with DHA in vitro and evaluated its cyto-
toxic effects with cell viability, cell morphology, induction
of apoptosis, determination of mitochondrial size and
monitoring of '<m changes. In addition to conventional
methods, FRET technique and fluorescence emission
spectral analysis in living cells were used for the first time
to determine DHA-induced caspase-3 activation. The pur-
pose of this study was to investigate the effects of DHA on
the anti-proliferation and apoptosis of the ASTC-a-1 cells
and to explore its molecular mechanism.
Materials and methods
Materials
Dihydroartemisinin was obtained from Bide Pharmaceu-
tical Corporation (Guangzhou, Guangdong Province,
China). Working solutions were prepared by dissolving
the compound in dimethyl sulphoxide (DMSO) before
experiments. The final concentration of DMSO was less
than 1% in all experiments. Lipofectamine2000 and
Mitotracker Red were purchased from Invitrogen
(Carlsbad, CA, USA). Rhodamine 123 (Rho123), Hoechst
33258 and PI were obtained from Sigma (St.Louis, MO,
USA). Cell Counting Kit (CCK-8) was purchased from
Dojindo Laboratories, Kumamoto (Japan). Annexin
V(FITC) apoptosis detection kit was obtained from
Bender Medsystems (Austria) and Ac-DEVD-AFC was pur-
chased from Alexis (Switzerland). Z-VAD.fmk, a broad
spectrum caspase inhibitor, was purchased from BioVi-
sion (CA, USA). SCAT3 plasmid was kindly provided by
Prof. Miura [24].
Cell culture and transfection
The human lung adenocarcinoma cell line (ASTC-a-1)
was obtained from the Department of Medicine, Jinan
University (Guangzhou, China). Dulbecco's modified
Eagle's medium (DMEM) was purchased from Gibco
(Grand Island, USA). For fluorescence studies, the cells
were transferred in 35-mm dish 24–48 h after transfec-
tion. The cell line stably expressing SCAT3 was obtained
from our previous studies [25,27] and all the cells were
cultured in DMEM supplemented with 10% fetal calf
serum (FCS) with 5% CO2 at 37°C in a humidified incu-
bator.
Cell viability assay
The cell viability after treatment with DHA was measured
by Cell Counting Kit-8 (CCK-8) assay. ASTC-a-1 cells were
suspended at a final concentration of 1 × 104 cells/well
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and cultured in 96-well flatbottomed microplate. After
exposure to DHA for 48 h, CCK-8 (10 Pl) was added to
each well of a 96-well flatbottomed microplate containing
100 Pl of culture medium and DHA (0, 1, 5, 10, 20, 30 Pg/
ml DHA, respectively) mixture, and the plate was incu-
bated for 1 h at 37°C. Moreover, cells were incubated with
20 Pg/ml of DHA for different periods of time (0, 6, 12,
24, 48 and 72 h). Viable cells were counted by absorbance
measurements at 450 nm using auto microplate reader
(infinite M200, Tecan, Austria). The OD450value was pro-
portional inversely to the degree of cell apoptosis. All
experiments were performed in triplicate on three sepa-
rate occasions.
Morphological examination for apoptosis
Cells were grown on the coverslip of a 35 mm chamber.
After being treated with 20 Pg/ml DHA for 48 h, the cells
were washed with PBS three times and incubated with 1
PM Hoechst 33258 and 1 Pg/ml PI for 20 min at room
temperature in the dark, respectively. Cells were then
washed three times with PBS and visualized under a Zeiss
fluorescent microscope (Axiovert 200 M). The images of
Hoechst 33258 were recorded using a digital camera
(Nikon, Tokyo, Japan) with 1280 × 1280 pixels resolu-
tion. PI was excited with 543 nm and recorded with a
600–650 nm long-pass filter. Moreover, after being incu-
bated with 10, 20 Pg/ml DHA for 48 h at 37°C, a laser
scanning confocal microscope (LSM510/ConfoCor2,
Zeiss, Jena, Germany) was used to examine ultrastructural
changes in ASTC-a-1 cells.
Annexin V and PI staining method
The appearance of phosphatidyl-serine on the extracellu-
lar side of the cell membrane was quantified by annexin
V/PI staining. After 20 Pg/ml DHA treatment for 24 and
48 h, control cells, STS-treated cells and DHA-treated cells
were stained with 5 Pl of annexinV-FITC and 10 Pl PI (10
Pg/ml) for 10 min at room temperature as recommended
by the manufacturer. Cells were subjected to fluorescence-
activated cell sorting (FACS) analysis using a flow cytom-
eter (FACS. Arla BD, USA) with apoptotic cells being
annexin V-positive/PI-negative.
Determination of mitochondrial size
Cells were cultivated on a coverslip of a 35 mm chamber.
At indicated times, after being treated with 20 Pg/ml
DHA, the cells were washed with PBS three times and
incubated with 0.1 PM Mito-tracker Red for 30 min at
room temperature in the dark. The cells were then washed
three times with PBS and visualized under confocal
microscope (LSM510/ConfoCor2, Zeiss, Jena, Germany).
Mito-tracker Red was excited at 633 nm and the emitted
light was recorded through a 650 nm long-pass filter. For
every condition tested, the size of 100–200 mitochondria
in at least 50 different cells is from three independent
experiments. The determination of the mitochondrial size
was carried out using Zeiss Rel3.2 image processing soft-
ware (Zeiss, Jena, Germany).
Measurement of Mitochondrial Membrane Potential 
('<m)
Rho123 was used to evaluate changes in '<m. After being
incubated with DHA for 48 h, the fluorescence images of
cells stained with potential-sensitive dye Rho123 were
monitored in real-time using a confocal microscope
(LSM510/ConfoCor2, Zeiss, Jena, Germany). Rho123 was
excited with 488 nm and the emission fluorescence was
recorded through a 454–600 nm filter. Cells were washed
with PBS three times, and stained with the Rho123 at 5
PM for 20 min in the dark at room temperature. Subse-
quently, cells were examined using a confocal microscope
after being washed with PBS three times.
The '<m was also measured by flow cytometry (FCM).
Cells were grown at a density of 1 × 105 cells in 12-well
flatbottomed microtiter plates. After treatment without
DHA or with DHA for 12, 24, and 48 h, cells preincubated
with 1 ml DMEM were collected and washed with PBS
three times. Cells in 1 ml PBS were stained with 1 PM
Rho123 for 30 min in dark at room temperature. After
that, cells were collected by centrifugation (1200 rpm, 3
min) and were washed with PBS three times and then
resuspended in 1 ml PBS. Fluorescence emitted from the
Rho123 was detected with a flow cytometer (FACS. Arla
BD, USA). Results were expressed as the proportion of
cells exhibiting high mitochondrial membrane potential
which was estimated by reduced fluorescence intensity
from Rho123.
Confocal and FRET acceptor photobleaching technique
Fluorescence imaging and FRET were performed on a con-
focal microscope (LSM510/ConfoCor2, Zeiss, Jena, Ger-
many). All the quantitative analysis of the fluorescence
images was performed by Zeiss Rel3.2 image processing
software (Zeiss, Jena, Germany). For time-lapse imaging,
culture dishes were mounted onto the microscope stage
equipped with a temperature-controlled chamber (Zeiss,
Jena, Germany).
According to the FRET technology, acceptor photobleach-
ing in single living cell was used to monitor the effect of
DHA on the caspase-3 activation. ASTC-a-1 cells stably
expressing SCAT3 were cultured in coverslip of a 35 mm
chamber after a treatment of DHA for 48 h. The acceptor
photobleaching of SCAT3 was performed with the highest
intensity of 514 nm laser on a confocal microscope.
SCAT3 was excited at 458 nm from an Ar-Ion laser and
CFP emission was collected through 470–500 nm band-
pass filters, and Venus (FRET-acceptor) emission was
recorded through a 530 nm long-pass filter.
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Fluorescence spectral analysis inside living cells
ASTC-a-1 cells stably expressing SCAT3 were cultured in
the 96-well flatbottomed microplate for 24 h. Then, cells
were incubated with various concentrations of DHA (0, 5,
10, 20 Pg/m1) for indicated times (0, 12, 24, 48 h) and 1
PM STS for 6 h in the presence or absence of 10 PM Z-
VAD.fmk. The emission spectra of the SCAT3 were
detected in living cells after the addition of DHA and STS
by auto microplate reader (infinite M200, Tecan, Austria).
In the meantime, we also needed to detect the emission
spectra of the empty cells that were not transfected and
considered them as the background emission spectra. The
step length of the scanning spectra is 2 nm. The excitation
wavelength of SCAT3 was 409–427 nm and the emission
fluorescence channel was 454–600 nm band-pass.
Fluorometric assay for Caspase-3 activity
For the detection of caspase-3 activity, PBS-washed cell
pellets (derive from either the medium or the adherent
cells) were resuspended in extract buffer [25 mM HEPES
(pH7.4), 0.1% TritonX-l00, 10% glycerol, 5 mM DTT, 1
mM phenylmethylsulfonyl fluoride, 10 mg/ml pepstatin,
and 10 mg/ml Leupeptin] and vortexed vigorously. 20 Pl
of extract (corresponding to 10% of the sample) were
incubated with the caspase-3 fluorogenic substrates Ac-
DEVD-AFC at 100 PM final concentration at room tem-
perature, and caspase-3 activity was measured continu-
ously by monitoring the release of fluorigenic AFC at
37°C. The excitation wavelength of AFC was 400 nm and
the emission wavelength was 530 nm using auto micro-
plate reader (infinite M200, Tecan, Austria).
Protein extraction and Western Blot analysis
The activation of caspase-3 in DHA-treated ASTC-a-1 cells
was examined by Western blotting which visualized the
processing of the inactive caspase proform to the catalyti-
cally active, smaller units. For Western blot analysis, the
cells were treated with 1 PM STS for 12 h, 20 Pg/m1 DHA
for 48 h and co-treatment with 20 Pg/m1 DHA and 10 PM
Z-VAD.fmk for 48 h. Collected cells were washed with
cold PBS. Cells were lysed in lysis buffer (50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 1% Triton-100, 1 mM PMSF and
protease inhibitor cocktail set I). Protein content was
quantitated using Bradford assay. Equivalent amounts of
total protein were resolved by 15% SDS-PAGE and trans-
ferred to nitrocellulose membranes (Millipore Co., Biller-
ica, MA, USA) following the conventional protocols.
Before being immunoblotted, the membranes were
blocked in 5% nonfat milk in TBST buffer (10 mM Tris pH
7.5, 150 mM NaCl, 0.1% Tween 20) for 1 h at room tem-
perature. The rabbit polyclonal anti-caspase-3 (Cell sign-
aling, Cat. No. 9746) was used at a dilution of 1:1,000 for
2 h at room temperature and secondary anti-rabbit IgG-
HRP (Rockland, Gilbertsville, PA, USA) was used at
1:1,000 for 1 h. Detection was performed using the LI-
COR Odyssey Infrared Imaging System (LI-COR, Inc.,
USA).
Statistical analysis
The results are expressed as mean ± standard deviation
(SD). Statistical analysis was performed with SPSS10.0
software for multiple comparisons. A value of P < 0.05
was considered to be statistically significant.
Results
Cytotoxicity of DHA on ASTC-a-1 cells
The effect of DHA on the ASTC-a-1 cell viability was
assessed using CCK-8. The proliferation of the cells was
inhibited in a dose-dependent manner at 48 h after treat-
ment with different concentration (0, 1, 5, 10, 20, 30 Pg/
ml) of DHA (Fig. 1a). Treatment with 20 Pg/ml of DHA
for different times (0, 6, 12, 24, 48, 72 h) demonstrated
that the cells growth was inhibited in a time-dependent
manner (Fig. 1b). These results showed that the prolifera-
tion of the cells could be effectively inhibited by DHA,
even at a very low treating-dose (1 Pg/ml) and a very short
treating-time (12 h).
Morphological changes of DHA-induced apoptosis in 
ASTC-a-1 cells
The Hoechst 33258, a sensitive fluorochrome to DNA,
was used to assess changes in nuclear morphology follow-
ing DHA treatment. The nuclei in normal cells exhibited
diffused staining of the chromatin (Fig. 2a: control). How-
ever, after exposure to 20 Pg/ml DHA for 48 h, the cells
underwent typical morphologic changes of apoptosis
such as chromatin condensation, margination and
shrunken nucleus (Fig. 2c: the arrows point to cells dis-
playing nuclear fragmentation) which were consistent
with STS-treated cells for 6 h (Fig. 2b), while the cell mem-
brane remained well defined (Fig. 2d: arrows). PI interca-
lates into double-stranded nucleic acids and it is excluded
by viable cells but can penetrate cell membranes of dying
or dead cells. As shown in Fig. 2e, PI didn't penetrate into
DHA-treated cells, demonstrating that DHA caused cell
apoptosis but not necrosis. In addition, we also used a
confocal microscope to examine the ultrastructural
changes in ASTC-a-1 cells. DHA significantly induced cell
shrinkage, membrane frill, blebbing, ovalisation and the
boundary between nucleus and cytoplasm became
blurred (Fig. 2h and Fig. 2i) while the control cells
retained their normal size and shape (Fig. 2f).
To further determine the form of DHA-induced cell death,
we stained cells in the absence and presence of DHA treat-
ment with fluorescent Annexin V and PI and quantified
their fluorescence by flow cytometry. As shown in Fig. 3a,
untreated cells displayed a low background of staining
with either Annexin V or PI. In contrast, Annexin V- and
PI-positive cells were dramatically increased in a time-
Journal of Biomedical Science 2009, 16:16 http://www.jbiomedsci.com/content/16/1/16
Page 5 of 15
(page number not for citation purposes)
dependent manner under incubation with 20 Pg/ml DHA
(Fig. 3b, c and 3d). These results also suggested that DHA
induced apoptosis in ASTC-a-1 cells.
FRET acceptor photobleaching analysis of DHA-induced 
caspase-3 activation in single living cells
Z-VAD.fmk, a broad spectrum caspase inhibitor, was used
to examine whether the caspases cascade was involved in
the DHA-induced ASTC-a-1 cell apoptosis. ASTC-a-1 cells
were pre-incubated with 10 PM Z-VAD.fmk 1 h before the
addition of DHA and STS. In addition, the dose of Z-
VAD.fmk we used in this study was based on our previous
work [29]. After treatment with 20 Pg/ml DHA in the pres-
ence and absence of Z-VAD.fmk, the cells viability was
examined at 0, 24 and 48 h, respectively. As shown in Fig.
4a, Z-VAD.fmk caused the marked attenuation of DHA-
induced apoptotic cell death compared with the cells
treated with DHA alone. The result demonstrated that the
activation of caspase-3 might play a crucial role in DHA-
induced apoptosis.
Furthermore, FRET acceptor photobleaching technique
was used to verify the effect of DHA on the caspase-3 acti-
vation in single living cell. Fig. 4b and 4d show the SCAT3
distribution inside living cells treated without or with
DHA. The acceptor (Venus) for the square area in Fig. 4b
was rapidly photobleached by 514 nm laser to verify the
normal expression of SCAT3 in single living cell, and we
found that the fluorescence intensity of CFP channel sig-
nificantly increased during the Venus photobleaching
(Fig. 4e), implying that there were FRET between CFP and
Venus in the SCAT3 reporter. The Venus photobleaching
experiments in the nuclei gave the similar results (data not
shown). However, for the DHA-treatment cells, the fluo-
rescence intensity of CFP channel was nearly invariable
during the Venus photobleaching (Fig. 4g) as well as STS
treatment (Fig. 4f), indicating that the SCAT3 had been
cleaved by the activated caspase-3 in DHA- and STS-
induced apoptosis.
Fluorescence emission spectral analysis of DHA-induced 
Caspase-3 activation in living cells
Fluorescence emission analysis of the cells expressing sta-
bly SCAT3 was also examined during DHA-induced apop-
tosis to further confirm caspase-3 activation in living cells.
Under the treatment of DHA (0, 5, 10, 20 Pg/ml) for 48 h,
the changes in fluorescence emission spectra of SCAT3
were shown in Fig. 4a. It is known that the strong peak at
524 nm of Venus is due to the occurrence of FRET between
the CFP and Venus. We found that the emission peak at
524 nm gradually decreased after 5 and 10 Pg/ml of DHA
treatment, and completely disappeared after 20 Pg/ml
DHA treatment, while the peak at 476 nm increased to the
maximum (Fig. 5a), implying that DHA activated caspase-
3 which cleaved SCAT3. Likewise, treatment with 20 Pg/
ml of DHA was adopted to determine the time-dependent
activation of caspase-3 for indicated time (0, 12, 24, 48 h),
and the changes in fluorescence emission spectra of
SCAT3 were also detected (Fig. 5b). The Fluorescence
spectra of SCAT3 inside living cells incubated with DHA
didn't have a marked change at 12 h, but the peak at 524
nm decreased at 24 h and completely disappeared at 48 h
after DHA treatment (Fig. 5b).
Fluorescence emission analysis was also used to examine
the inhibition of Z-VAD.fmk on the DHA-induced cas-
Figure 1
Cell viability was measured by CCK-8 assay via con-
centration- and time-dependent manners in vitro. a 
ASTC-a-1cells were seeded into 96-well flatbottomed micro-
plate and incubated with various concentrations of DHA for 
48 h. b Cells were seeded into 96-well flatbottomed micro-
plate and incubated with 20 Pg/ml of DHA for the indicated 
times. Data analyzed with SPSS10.0 software are expressed 
as mean ± SD. n = 4 wells for all CCK-8 assay. *P < 0.05, **P 
< 0.01, compared with control.
a 
b 
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Apoptosis induced by DHA in ASTC-a-1cellsFigure 2
Apoptosis induced by DHA in ASTC-a-1cells. The cells were treated with 20 Pg/ml of DHA for 48 h. Nuclear morphol-
ogy was detected by Hoechst33258 staining and examined by fluorescence microscope. a Control cells with dispersive light 
blue nuclei and intact structure. c With 20 Pg/ml of DHA treated, cell shrinkage, chromatin condensation and margination in 
the nucleus were visualized as well as STS treatment for 6 h (b: positive control). d The same cells as panel c showing that the 
plasma membrane remained well defined. e PI didn't penetrate into DHA-treated cells, demonstrating that DHA caused cell 
apoptosis but not necrosis. f DIC morphology of control cells was determined and photographed by the confocal microscope. 
(h, i) 10, 20 Pg/ml DHA treated respectively: cell shrinkage, ovalisation, membrane frill, blebbing and the boundary between 
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pase-3 activation. We found that Z-VAD.fmk significantly
attenuated the decrease of 524 nm peak compared with
20 Pg/ml DHA treatment alone for 48 h (Fig. 5d), imply-
ing that caspase-3 participated in the DHA-induced cell
apoptosis. The same result was shown in Fig. 5c under the
STS treatment.
Detection of the DHA-induced caspase-3 activation by 
AFC and Western blot analysis
AFC release is an indicator of caspase-3 activation [30].
Activated caspase-3 but not pro-caspase-3 does exert pro-
teolytic activation on the Ac-DEVD-AFC substrate unless
activated [30]. As shown in Fig. 6a, after incubation with
Ac-DEVD-AFC for 1 h, a nearly 2-fold increase of caspase
activity was observed at 48 h after DHA treatment com-
pared with control. In contrast, the cleavage of Ac-DEVD-
After 20 Pg/ml DHA treatment for 24 and 48 h, control cells, STS-treated cells and DHA-treated cells were stained with 5 Pl of annexinV-FITC and 10 Pl propidium io ide (10 Pg/ml) for 10 min before being subjected to flow cytometry nalysisFigur  3
After 20 Pg/ml DHA treatment for 24 and 48 h, control cells, STS-treated cells and DHA-treated cells were 
stained with 5 Pl of annexinV-FITC and 10 Pl propidium iodide (10 Pg/ml) for 10 min before being subjected to 
flow cytometry analysis. a Untreated cells displayed a low background of staining with either Annexin V or PI. b Positive 
control (1 PM STS-treated cells for 6 h). (c, d) In contrast, Annexin V- and PI-positive cells were dramatically increased in a 







a  Control 
12.5 45.1
17 25.4 
b  STS 6h 






c  DHA 24h 
25.2
Journal of Biomedical Science 2009, 16:16 http://www.jbiomedsci.com/content/16/1/16
Page 8 of 15
(page number not for citation purposes)
Figure 4 (see legend on next page)
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AFC in response to caspase-3 activation was remarkably
inhibited under the co-treatment with DHA and Z-
VAD.fmk. These results demonstrated that caspase-3 was
involved in the DHA-induced apoptosis, which was con-
sistent with the result by FRET analysis.
Western blot analysis was performed to further confirm
that caspase-3 activation was involved in DHA-induced
apoptosis. The result of Western blot analysis of caspase-3
in ASTC-a-1 cells after treatment with STS (as a positive
control), DHA and Z-VAD.fmk was shown in Fig. 6b. Cas-
pase-3 was primarily present as the 35 kDa proform (Fig.
6b lane 1) for the untreated ASTC-a-1 cells. Following
exposure to STS for 12 h, the processing of caspase-3 acti-
vation was evident by loss of the proform and appearance
of processed caspase-3, p17 fragment from cleavage of
caspase-3 (Fig. 6b lane 2), and treatment with DHA for 48
h showed the same result (Fig. 6b lane 3). Moreover,
DHA-induced caspase-3 activation was blocked under the
co-treatment with DHA and Z-VAD.fmk (Fig. 6b lane 4).
These data showed that 48 h incubation with 20 Pg/ml
DHA induced the activation of caspase-3, further indicat-
ing that caspase-3 was involved in the DHA-induced
apoptosis.
Alteration of mitochondrial morphology in DHA-treated 
cells
Given the crucial role that mitochondria play in the apop-
totic process, we are interested in evaluating the DHA abil-
ity to trigger mitochondrial events of apoptosis. One of
the mitochondrial events related to DHA-induced apop-
tosis is the ultrastructural changes in cellular mitochon-
dria. As shown in Fig. 7a and Fig. 7b, treating the cells with
DHA for 48 h influenced the morphology of the cellular
mitochondria in ASTC-a-1cells. Fig. 7c and Fig. 7d showed
the spatial distribution of mitochondrial sizes indicating
as the white line in Fig. 7a and Fig. 7b. We found that the
size of mitochondria gradually increased after DHA treat-
ment compared with control (Fig. 7e).
Measurement DHA-induced loss of mitochondrial 
membrane potential ('<m)
Another important mitochondrial events related to apop-
tosis is the permeability which is associated with a drop in
'<m [17]. Cells were incubated with 20 Pg/ml of DHA for
48 h, and then we monitored the dynamics of the DHA-
induced loss of '<m by Rho123, a potential-sensitive dye,
using confocal microscope (Fig. 8a). The loss of '<m was
visualized as indicated by the reduction of Rho123 fluo-
rescence intensity. Individual traces of two typical cells
treated with DHA were given in Fig. 8b. Moreover, mean
trace of five cells calculated from single cell kinetics was
shown in Fig. 8c. Surprisingly, we also found a strange
phenomenon that a sudden increase of fluorescence
intensity occurred within 5 min in some cells and subse-
quently disappeared within 15 min (data not shown).
Moreover, we used FCM to further confirm the collapse of
'<m in DHA-induced apoptosis by detecting '<m at 0, 12,
24 and 48 h after 20 Pg/ml DHA treatment, the corre-
sponding percentage of cells with Rho123 fluorescence
were 94%, 74%, 62.1% and 28.9% (Fig. 8d), implying
that DHA induced a time-dependent loss of '<m.
Discussion
Artemisinin is an effective novel anti-malarial drug with
low toxicity. No toxicity has been reported with oral
administration [31]. Although it has been reported that
artemisinin inhibits cell proliferation in many types of
cancers [6-14], it is still not known whether artemisinin
and its derivatives work as growth inhibitors in ASTC-a-1
cells. Endoperoxide function is at least in part responsible
for the growth inhibitory activity of artemisinins, since the
reduction to an ether bond greatly reduces cytotoxicity
[32]. Other reports, however, pointed out that the
endoperoxide was not absolutely necessary for the effects
against tumor cells [33]. Our results in this study sug-
gested that DHA effectively exerted cytotoxcity on ASTC-a-
1 cells even at a very low dose. Furthermore, the presence
of DHA inhibited the growth of ASTC-a-1 cells in a dose-
and time-dependent manner as shown in Fig. 1.
Hoechst33258 and PI staining as well as flow cytometry
analysis showed that DHA significantly induced apoptosis
DHA-induced apoptosis was attenuated by Z-VAD.fmk and Caspase-3 activation was determined using FRET receptor photob-leaching te hnique in ngle living cellsFigure 4 (s e previous page)
DHA-induced apoptosis was attenuated by Z-VAD.fmk and Caspase-3 activation was determined using FRET 
receptor photobleaching technique in single living cells. a The effect of DHA and STS (as a positive control) on apop-
tosis attenuated by Z-VAD.fmk was determined using CCK-8 assay. The ASTC-a-1cells were treated with 20 Pg/ml DHA and 
with or without 10 PM of Z-VAD.fmk for 24 and 48 h, respectively. The result was expressed as mean ± SD of three determi-
nations. n = 3 wells for CCK-8 assay. *P < 0.05, **P < 0.01, compared with control. (b, c, d) Fluorescence images of cells stably 
expressing SCAT3. The circled parts were the bleaching area. (e, f, g) FRET receptor photobleaching assay determined the 
activation of caspase-3 during DHA- and STS-induced apoptosis in single cells. e Control. f Positive control (1 PM STS-treated 
cells for 6 h). g After the treatment of 20 Pg/ml DHA for 48 h, fluorescence intensity of CFP channel was nearly invariable dur-
ing the Venus photobleaching, implying that SCAT3 had been cleaved by the activated caspase-3.b-d: Scale Bar: 10 Pm.
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DHA induces dose- and time-dependent activation of caspase-3 in living cells which was attenuated by Z-VAD.fmk (10 PM)Figure 5
DHA induces dose- and time-dependent activation of caspase-3 in living cells which was attenuated by Z-
VAD.fmk (10 PM). a The emission spectral analysis of the SCAT3 in living cells stably expressing SCAT3 after 0, 5, 10, 20 Pg/
ml DHA treatment for 48 h. The emission peak at 524 nm gradually decreased after 5 and 10 Pg/ml DHA treatment, and com-
pletely disappeared after 20 Pg/ml DHA treatment, while the peak at 481 nm increased to the maximum, implying that DHA 
activated caspase-3 which cleaved SCAT3. b 20 Pg/ml DHA was adopted to determine the time-dependent activation of cas-
pase-3 for indicated time (0, 12, 24, 48 h). The Fluorescence spectrum of SCAT3 didn't have an obvious change at 12 h, but the 
emission peak at 524 nm decreased at 24 h and completely disappeared after 48 h DHA treatment. d The inhibition of DHA-
induced caspase-3 activation was triggered by Z-VAD.fmk. The reoccurrence of FRET effect was indicative of the inhibition of 
DHA-mediated caspase-3 activation under the co-treatment of DHA and Z-VAD.fmk as well as 1 PM STS treatment (c: as a 
positive control) for 6 h.
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ȝ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of ASTC-a-1 cells (Fig. 2 and Fig. 3). The concentration of
DHA used in our study was below its clinical dosage,
which was usually used for treating of malaria [34].
It has been reported that mitochondria play a crucial role
in the apoptotic process. Mitochondrial dysfunctions
including the loss of mitochondrial membrane potential
('<m), permeability transition, and release of cytochrome
c from the mitochondrion into the cytosol are associated
with apoptosis [35]. Opening of permeability transition
pores (PTP) in the mitochondrial inner membrane causes
the mitochondrial permeability transition (MPT) and
leads to mitochondrial swelling, membrane depolariza-
tion, and release of intramitochondrial solutes [17]. As we
known, the mitochondrial transversal section (width) is
the most constant dimension of organelle and variations
on this parameter reflects an alteration of the morphology
of mitochondria. Here, we determined the alteration of
mitochondrial morphology and found an obvious dis-
mantling of the mitochondrial network and mitochon-
drial swelling induced by DHA treatment for indicated
times (Fig. 7).
Furthermore, we measured alteration of '<m in DHA-
treated ASTC-a-1 cells. In this study, the loss of '<m in
response to the loss of fluorescence intensity was visual-
ized in DHA-treated cells (Fig. 8a). Interestingly, as
observed in some cells, DHA triggered a rapid loss of '<m
within 15 min following a sudden increase within 5 min
(data not shown). Santamaría et al found that the early
increase in TMRM+ fluorescence after STS addition may be
due to a true increase in '<m or to the apparent increase
in mitochondrial volume, while the increase in '<m was
abrogated by oligomycin, an inhibitor of the H+-ATP syn-
thase [36]. They also suggested that H+-ATP synthase
maintained high '<m induced by STS [36]. H+-ATP syn-
thase may involve in the rapid increase of fluorescence
intensity before loss of '<m induced by DHA treatment.
Moreover, the loss of '<m in DHA-treated cells was fur-
ther investigated through flow cytometry analysis (Fig
8d).
In some cell lines, caspase-3 plays a direct role in proteo-
lytic cleavage of cellular proteins responsible for progres-
sion to apoptosis [18]. The activation of caspase-3 induces
PARP cleavage, chromosomal DNA break and finally the
occurrence of apoptosis [20]. Incubation of ASTC-a-1 cells
with Z-VAD.fmk in addition to DHA significantly reduces
the cell growth inhibition effect of DHA compared with
DHA alone (Fig. 4a), indicating that caspase cascades were
involved in the apoptotic cell death induced by DHA. We
used FRET acceptor photobleaching and emission spectral
analysis techniques to monitor the DHA-induced caspase-
3 activation in living cells.
DHA induced caspase-3 activation in ASTC-a-1 cellsFigure 6
DHA induced caspase-3 activation in ASTC-a-1 cells. 
Cells were incubated with 1 PM STS for 12 h, 20 Pg/m1 
DHA for 48 h and co-treatment with 20 Pg/m1 DHA and 10 
PM Z-VAD.fmk for 48 h, and then were analyzed by caspase-
3 activity and Western Blot assay. a Caspase-3 activity was 
measured using the fluorescence substrate Ac-DEVD-AFC as 
described in Materials and Methods. The activation index was 
determined as the ratio between the activity in treated cells 
and untreated cells. Data analyzed with SPSS10.0 software is 
representative of three identical experiments. **P < 0.01, 
compared with control cells; ##P < 0.01, compared with only 
DHA-treated cells. b The cells were treated with STS as a 
positive control showed the decreased proform and the 
increased cleavage of caspase-3. DHA-treated cells also 
showed the loss of the proform and appearance of cleaved 
caspase-3 compared with control. Moreover, DHA-induced 
caspase-3 activation was blocked under the co-treatment 
with DHA and Z-VAD.fmk.
a 
b 
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Treating ASTC-a-1 cells with DHA induced alteration of mitochondrial morphologyFigure 7
Treating ASTC-a-1 cells with DHA induced alteration of mitochondrial morphology. Cells were loaded with Mito-
tracker-red and then treated with 20 Pg/ml DHA for analysis.a The mitochondria within the untreated control cells showed 
small-defined mitochondria. b The mitochondria of DHA-treated cells were obviously swollen. The right-hand panels repre-
sent enalrged views of the boxed regions within the left-hand panels, as indicated. (c, d) The spatial distribution of mitochon-
drial sizes indicated as the white line in a and b, respectively. e For every condition tested, the width of 100–200 mitochondria 
in at least 50 different cells was determined. Data analyzed with SPSS10.0 software are expressed as mean ± SD. *P < 0.05, **P 
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Loss of mitochondrial membrane potential ('<m) was involved in DHA-triggered apoptosisFigure 8
Loss of mitochondrial membrane potential ('<m) was involved in DHA-triggered apoptosis. a The dynamics of 
the loss of the mitochondrial membrane potential were monitored by the potential-sensitive dye Rho123 under confocal 
microscope in DHA-treated ASTC-a-1 cells for 48 h. Scale Bar: 10 Pm. b Individual traces of two typical cells treated with 
DHA. c Mean trace of five cells calculated from single cell kinetics by setting the time of onset of the decrease of fluorescence 
intensity to zero. d The precentage of cells with rodamine 123 fluorescence were 94%, 74%, 62.1% and 28.9% at 0, 12, 24 and 
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The results from Fig. 4 and 5 showed that Z-VAD.fmk
attenuated the activation of caspase-3 in DHA-treated
ASTC-a-1 cells, demonstrating that caspase-3 activation is
a key mechanism of DHA-induced apoptosis which was
confirmed by caspase-3 activity and western blotting anal-
ysis (Fig. 6). DHA initiates activation of caspase and in
turn leads to apoptotic cell death. Although the mecha-
nism by which DHA activates caspases on ASTC-a-1 cells
remains unclear, these results provide a correlation
between caspase-3 activity and DHA-induced apoptosis,
and deserve to be further pursued.
Conclusion
In summary, DHA was found to have a potent ability in
influencing ASTC-a-1 cells behavior. These results show
for the first time that DHA can inhibit the proliferation
and induce dose- and time-dependent apoptosis via cas-
pase-3-dependent mitochondrial pathway in ASTC-a-1
cells. Furthermore, our data provides evidence of poten-
tial implications for the rational application of DHA as a
novel potential anticancer drug against human lung ade-
nocarcinoma, although much work is needed before DHA
can be fully utilized in clinical treatments.
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